| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 20.98B | 20.87B | 21.49B | 20.69B | 19.74B | 19.71B |
| Gross Profit | 5.75B | 5.70B | 6.01B | 4.97B | 4.58B | 4.68B |
| EBITDA | 1.72B | 1.71B | 1.84B | 1.23B | 1.06B | 1.04B |
| Net Income | 791.63M | 792.63M | 959.63M | 559.00M | 412.78M | 420.88M |
Balance Sheet | ||||||
| Total Assets | 18.46B | 19.02B | 20.64B | 18.88B | 17.96B | 17.03B |
| Cash, Cash Equivalents and Short-Term Investments | 4.26B | 3.80B | 4.70B | 3.48B | 2.95B | 2.24B |
| Total Debt | 4.54B | 4.63B | 4.52B | 4.14B | 4.28B | 4.48B |
| Total Liabilities | 9.16B | 9.53B | 11.66B | 10.95B | 10.44B | 9.84B |
| Stockholders Equity | 9.30B | 9.49B | 8.98B | 7.93B | 7.52B | 7.18B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -282.00M | 1.40B | 1.08B | 1.18B | 370.61M |
| Operating Cash Flow | 0.00 | -224.24M | 1.54B | 1.12B | 1.22B | 501.78M |
| Investing Cash Flow | 0.00 | -66.84M | -146.03M | -141.11M | -42.94M | -123.94M |
| Financing Cash Flow | 0.00 | -609.26M | -173.50M | -445.45M | -466.68M | -420.24M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥37.65B | 7.75 | ― | 3.59% | 6.91% | 13.17% | |
77 Outperform | ¥48.00B | 14.35 | ― | 3.74% | 3.70% | 12.26% | |
74 Outperform | ¥12.10B | 16.74 | ― | 2.89% | 2.56% | 17.52% | |
66 Neutral | ¥129.11B | 10.42 | 12.89% | 3.40% | 2.98% | 41.11% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | ¥6.13B | 4.98 | ― | 4.13% | 2.76% | -10.23% | |
50 Neutral | ¥475.90B | 16.11 | 1.44% | 4.80% | 0.68% | ― |